Materialise CEO Calls for Improved Clinical Measurement Standards to Help Expand Medical 3D Printing
There’s no denying that 3D printing technology is steadily changing the shape of the medical industry, whether it be through anatomical models, guides, implants, or the many other applications that continue to become more widely accepted and used in healthcare services across the world. One of the top providers of the healthcare-driven 3D printing revolution is the Leuven, Belgium-based Materialise NV. Focused on academia, medical device companies, and the hospital environment, Materialise has gained quite a stronghold on the medical industry over the past few years.
Last year, we covered the service bureau’s partnership with medical product development company Kapstone Medical, as well as a five-year deal with Japan’s Medical Dynamic Marketing, Inc., who partnered with Materialise for 3D printed hip replacements. Their biomedical software, called the Mimics Innovation Suite, is respected across the industry for its quality patient-specific 3D modeling capabilities. Just recently, Mimics proved itself ready-and-able to help provide successful thyroplasty surgery to trans women , and has also just become the go-to 3D modeling software for the Japan-based healthcare provider Canon Lifecare Solutions.
So it seems safe to say that Materialise is the proper leader for creating more generally accepted measurement standards for medical-based 3D printing, and their CEO, Fried Vancraen, is calling for an experienced initiative to develop this tightened approach. With a globally accepted set of guidelines, the medical 3D printing industry can better persuade physicians, hospitals, and policy makers to adopt this increasingly valuable technology. With a developed set of clinical measurement standards for the medical use of 3D printing, government bodies and insurance companies are also more likely to add medical 3D printing to their approved list of medical procedures and devices, which will allow patients access to the most modern, technologically-driven healthcare solutions.
“There have been several initiatives aimed at properly measuring and validating the clinical benefits of medical 3D Printing, but all have suffered from a lack of coordination and agreed-upon research methodologies,” Vancraen stated. “The fact is, we can only be successful if we take an evidence-based approach across the industry, acting in concert with a set of protocols, methodologies and measurement guidelines. With the proper scientific rigor, our ambition of gaining widespread acceptance of medical 3D Printing will be realized more swiftly, and the patients whom we aim to serve will benefit the most.”
To help jumpstart the initiative, Materialise will lead the way by studying and designing an evidence-based approach to create these clinical standards, which will include an economical, clinical, engineering and patient-based focus. According to Vancraen, Materialise’s goal is to set the groundwork for more solid measurements, which will help validate a variety of medically-driven 3D printing applications, including anatomical models, patient-specific guides, and implants. With these plans, Materialise can help ingrain 3D printing technology even more deeply into the medical industry by producing more solid clinical evidence, which should further incline physicians, hospitals, and other medical organizations to implement 3D printing into their own healthcare services.
Materialise will be presenting this on-going initiative at Building Evidence for 3D Printing Applications in Medicine, an event hosted by SME and sponsored by Materialise. This event will follow the RAPID Conference, an annual 3D printing conference that will take place at the Orange County Convention Center in Orlando, Florida from May 19-20. If you’d like to learn more about this well-rounded approach to creating better clinical measurement standards for 3D printing, you can either register for the upcoming event or—for those not in the vicinity of the in-person discussion—request more information from the Materialise website. Discuss in the Materialise 3D Printing and Clinical Evidence forum over at 3DPB.com.[Source: Materialise NV via Ortho Spine News]
You May Also Like
SmarTech Analysis Launches New Data Product Addressing Parts Produced by Additive Manufacturing
Industry analyst firm SmarTech Analysis today announced a new data product geared towards addressing the critical metric of additively manufactured parts produced. The Additive Manufacturing Applications Market Analysis Report is a...
3DPOD Episode 14: Consumer and Affordable 3D Printers
This 3DPod Episode is filled with opinion. Here we look at our favorite affordable desktop 3D printers. We evaluate what we want to see in a printer and how far...
Hybrid Manufacturing: Opportunities for Additive Manufacturing and CNC Companies
“Hybrid Manufacturing Markets: Opportunities for Additive Manufacturing and CNC Companies”, a new report from SmarTech Analysis, digs down into the market for hybrid manufacturing systems, which combine AM with subtractive...
3DPOD Episode 13: Support Free Metal AM with Velo3D’s Zach Murphee
Velo3D was a mysterious stealth startup that unveiled a potentially breakthrough metal technology last year. Revealing more about its capabilities, partnering with service partners, and working towards printing aerospace parts...
View our broad assortment of in house and third party products.